Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

24 trials with published results (11%)

Research Maturity

112 completed trials (53% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.8%

8 terminated out of 213 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

13%

28 trials in Phase 3/4

Results Transparency

21%

24 of 112 completed with results

Key Signals

24 with results93% success

Data Visualizations

Phase Distribution

187Total
Not Applicable (45)
Early P 1 (3)
P 1 (91)
P 2 (20)
P 3 (13)
P 4 (15)

Trial Status

Completed112
Unknown44
Recruiting26
Not Yet Recruiting11
Terminated8
Active Not Recruiting6

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 112 completed trials

Clinical Trials (213)

Showing 20 of 20 trials
NCT07454538Not ApplicableCompletedPrimary

Empowering Preschool Children With Personal Safety Skills

NCT07557966Not ApplicableCompletedPrimary

Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis

NCT06844487Phase 3Active Not Recruiting

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

NCT05776550Active Not RecruitingPrimary

Safety and Efficacy of Distal Radial Access (SAFE-BOX)

NCT07000669CompletedPrimary

Bilateral Peribulbar Block for Cataract Surgery

NCT05032976Active Not Recruiting

Korea Comirnaty Post-marketing Surveillance

NCT07522112Not ApplicableNot Yet RecruitingPrimary

Evaluating a Shared Decision-making Intervention for Families About Firearm Storage

NCT07016802Phase 1RecruitingPrimary

A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

NCT06818994Phase 1Recruiting

Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer

NCT06760208Recruiting

A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

NCT07461220Phase 1Recruiting

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

NCT04592640Early Phase 1Recruiting

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

NCT07438236Not ApplicableCompleted

Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students

NCT07434856Not Yet Recruiting

Evaluation of a Sexual Violence and Intimate Partner Violence Primary Prevention Program Implemented in Drinking Establishments

NCT06345950Not ApplicableCompleted

Pharmacokinetics and Safety of a New Micellar Glutathione Formulation

NCT05265689Not ApplicableCompleted

Study to Improve Adolescent Bicycling Safety

NCT07286656Phase 1RecruitingPrimary

A Study of GensSci098 in Subjects With Graves' Disease

NCT06569758Phase 1RecruitingPrimary

A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

NCT07312643Phase 1Completed

Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule

NCT06310811Not ApplicableSuspendedPrimary

Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Scroll to load more

Research Network

Activity Timeline